The Veozah Diet: Caffeine, Alcohol, and What Actually Interacts

Does Veozah actually interact with caffeine?

Start with the mechanism, because that's the part forums tend to skip past. Fezolinetant, the active ingredient in Veozah, is broken down almost entirely by one liver enzyme called CYP1A2. Caffeine happens to travel through that same enzyme on its way out of your system, which is exactly why the two keep getting mentioned in the same breath online. Sharing a metabolic pathway isn't the same thing as interacting with each other, though, and that distinction is most of the answer here.

Veozah's FDA prescribing information does not name caffeine anywhere in its interactions or contraindications sections, based on the current label. What it contraindicates is a defined pharmacological category — CYP1A2 inhibitor drugs, generally described as spanning weak, moderate, and strong inhibitors rather than naming one specific drug — because those drugs block the enzyme that clears fezolinetant and let it build up in the blood. Some consumer drug-interaction checkers still flag caffeine out of caution, reasoning that anything metabolized by CYP1A2 could theoretically compete for the same enzyme, but they say so explicitly: this hasn't actually been studied with caffeine, and it's a theoretical extension of the drug-class warning, not a finding of its own.

So no, an ordinary coffee habit isn't the interaction to worry about here, and there's no dose adjustment, timing rule, or cup-count cited anywhere for coffee, tea, or energy drinks. What forums are actually reaching for, usually without naming it correctly, is the CYP1A2 research on smoking — a real, still-unsettled tension covered in full in how long Veozah takes to work — and that mechanism runs in the opposite direction from caffeine's. More on that below.

What the label actually warns about: fluvoxamine and CYP1A2 inhibitor drugs

Fluvoxamine is the drug the FDA actually studied for this interaction, and the numbers explain why the combination earned a contraindication instead of a caution. Coadministering fluvoxamine — an antidepressant and a strong CYP1A2 inhibitor — raised fezolinetant's peak blood level by roughly 60 to 80%, and pushed total drug exposure up by roughly eight- to nine-fold, depending on which analysis of the trial data you're reading. Either way, that's not a subtle shift; it's the kind of change that turns a standard dose into something closer to an overdose, which is why the label doesn't soften the language around it.

The contraindication is generally described as covering CYP1A2 inhibitor drugs as a class, not fluvoxamine by name alone — in practice, that means a prescriber checks your full medication list against that category before starting Veozah, rather than screening for one drug name. This is the same mechanism our Veozah vs. HRT comparison walks through in its safety section, worth a read if you're weighing the two side by side. As with the caffeine question above, this page states the contraindication's scope as it's commonly described in secondary clinical summaries; if you're checking a specific other medication against Veozah, confirm the exact wording with your pharmacist or prescriber against the current label rather than relying on any secondhand summary, this one included.

The difference from caffeine, mechanically, is that fluvoxamine and drugs like it were studied specifically for this interaction, dosed consistently, and measured in a controlled trial — not consumed in wildly different amounts by different people at different times of day. That gap is the entire distance between "contraindicated" and "theoretically worth mentioning."

Can you drink alcohol on Veozah, given the liver boxed warning?

Veozah's FDA label doesn't list alcohol as a contraindication, and it isn't named in the drug-interactions section either. A handful of clinical interaction-checker tools flag a theoretical caution, reasoning that acute alcohol intake can temporarily affect liver enzyme activity — but that's a database inference, not label language, and it hasn't been studied directly with fezolinetant.

The real reason alcohol deserves more thought here than it would with an average medication isn't a drug interaction at all — it's the boxed warning. On December 16, 2024, the FDA added its most serious labeling action to Veozah, after a postmarketing case of serious liver injury, and prescribers now check liver function at baseline, then at months 1 and 2, then again at months 3, 6, and 9. Alcohol is an independent stressor on the same organ that schedule exists to watch, and heavier or regular drinking is exactly the kind of variable that can muddy a liver-enzyme result or add real risk on top of a rare one that's already being monitored for.

None of that makes an occasional drink the emergency the internet sometimes makes it sound like — for a woman with normal baseline liver function, moderate drinking isn't the same risk as heavy or daily drinking. What's worth knowing either way is the actual pattern that triggered the boxed warning in the first place, since it's specific enough to recognize:

• Fatigue that doesn't track with anything else going on
• Yellowing of the skin or eyes (jaundice)
• Dark urine
• Pale or clay-colored stools
• Unusual, unexplained abdominal pain

That pattern is worth same-day medical attention rather than waiting it out, and worth mentioning your alcohol intake if you're seen — it helps your clinician read the full picture rather than guess at it.

Does smoking change how well Veozah works?

Briefly, since the fuller version of this lives elsewhere: smoking induces CYP1A2 rather than inhibiting it, which is the opposite direction from fluvoxamine. Veozah's current FDA label states no clinically significant difference in fezolinetant exposure was seen in smokers during the registration trials, but a 2024 pharmacology study found exposure in smokers running roughly half that of nonsmokers — a genuine, unresolved tension in the research rather than a settled answer. If smoking status is relevant to you, that page walks through both findings side by side rather than repeating them here.

What about grapefruit and other classic drug-interaction foods?

Grapefruit's reputation as a drug-interaction food comes from one specific enzyme, CYP3A4, and a long list of medications — statins, some blood pressure drugs, plenty of others — that happen to be metabolized by it. Fezolinetant isn't one of them. It's metabolized primarily by CYP1A2, with a smaller contribution from two other enzymes, and CYP3A4 doesn't meaningfully enter the picture at all.

So the reflexive "better check with grapefruit" instinct, reasonable as it is for plenty of prescriptions, doesn't actually apply to Veozah. There's no established grapefruit interaction, and nothing in the label or trial data suggests one. The enzyme that matters here is CYP1A2 — the same thread running through the caffeine, smoking, and fluvoxamine questions above, not the citrus one.

Should you take Veozah with or without food?

This one has a simple answer: the label says to take the 45mg tablet once daily, with or without food. There's no fasting window, no requirement to take it at a particular point relative to a meal, and no absorption penalty either way. If taking it on an empty stomach makes the GI side effects covered next feel worse, taking it with food is a reasonable adjustment — a comfort choice, not a rule you'd be breaking by doing it the other way.

Could your coffee be making Veozah's side effects worse, even without a true drug interaction?

This is a genuinely different question from the interaction question above, and it's worth keeping the two separate. Veozah's own trial data shows a real, if modest, uptick in a few side effects compared with placebo over a year of treatment: abdominal pain in roughly 4.3% of women on the 45mg dose versus 2.1% on placebo, diarrhea in about 3.9% versus 2.6%, and insomnia in close to 3.9% versus 1.8%.

Caffeine, entirely on its own, is a well-known contributor to exactly those two categories — it can worsen reflux and stomach upset, and it's one of the most common, most fixable causes of trouble falling or staying asleep. A woman drinking several cups a day, especially later in the afternoon, who's also dealing with Veozah's own GI or sleep side effects isn't necessarily looking at a drug interaction — she may be looking at two separate, additive causes of the same symptom. Shifting caffeine earlier in the day, or cutting back if insomnia is already a problem, is worth trying before assuming the medication is the whole story.

The same logic applies to alcohol and the GI side effects specifically — a nightcap on a stomach already a little more prone to upset from the drug tends to make that upset more noticeable, not because of any liver-enzyme interaction, but because both things irritate the same system independently.

Does Veozah cause weight gain or weight loss, and does diet factor in?

No documented weight effect shows up in Veozah's trial data — weight change doesn't appear on the list of reported adverse reactions in either direction, which is a real difference from how some other menopause and metabolic medications behave. That tracks with how the drug actually works: fezolinetant blocks a receptor involved in thermoregulation in the brain, not the appetite or gut-hormone pathways that drive weight change with something like a GLP-1.

If your weight shifts after starting Veozah, the more likely explanation is something else changing at the same time — sleep improving once night sweats ease up, activity levels shifting, or the broader metabolic changes that come with this stage of life regardless of medication. Diet doesn't factor into whether Veozah works the way it does with drugs that act through digestion or appetite; there's no eating pattern that makes fezolinetant more or less effective.

Is there an official Veozah diet plan? What actually helps day to day

No. Astellas doesn't publish a Veozah-branded eating plan the way some GLP-1 manufacturers do for their drugs, and there's no clinical reason one would need to — food doesn't change how fezolinetant is absorbed or how well it controls hot flashes.

What actually helps is narrower and more practical than a diet plan would be: manage the same side effects caffeine and alcohol can independently make worse, take the tablet at a consistent time of day, with or without food, whichever settles better for you, and know the real red flags — persistent liver-injury symptoms, not routine early GI upset — well enough to act on them quickly rather than second-guessing every twinge. That's a shorter, more honest list than the internet's version of a "Veozah diet."

Where to get Veozah and what it actually costs

If the interaction questions above were what held you back, the practical piece left is access and price. Veozah lists at $583.50 a month, and pharmacy counters typically charge closer to $773 in cash — high enough that a lot of women assume it's out of reach before checking what insurance and the manufacturer's copay card actually do to that number. A SingleCare or GoodRx coupon brings the cash price down to somewhere between $467 and $545 depending on the pharmacy, and commercially insured women who enroll in the Astellas savings program typically land around $30 a month after a free first fill.